Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ONCOGENEX PHARMACEUTICALS Inc OGXI

Healthcare Biotechnology
"OncoGenex Pharmaceuticals Inc is a biopharmaceutical company focused on the development of cancer treatment resistance. It has developed Apatorsen to block the production of heat shock protein 27, or Hsp27, that promotes treatment resistance in cancer."

Recent & Breaking News (NDAQ:OGXI)

Achieve Life Sciences Announces Closing of Merger with OncoGenex Pharmaceuticals

PR Newswire August 1, 2017

Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Form S-4 Registration Statement Declared Effective by SEC

PR Newswire June 13, 2017

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2017

PR Newswire May 15, 2017

OncoGenex to Report First Quarter 2017 Financial Results on May 15, 2017

PR Newswire May 9, 2017

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Oncogenex Pharmaceuticals, Inc. - OGXI

PR Newswire May 5, 2017

Research Reports Coverage on Biotech Stocks -- Novan, Stemline Therapeutics, BioDelivery Sciences, and OncoGenex Pharma

PR Newswire April 25, 2017

Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma

PR Newswire March 24, 2017

Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Cytisine Symposium at the Annual Society for Research in Nicotine and Tobacco Conference ("SRNT")

PR Newswire March 8, 2017

Achieve Life Science and OncoGenex Pharmaceuticals Announce Strategic Collaboration with the National Institutes of Health to Advance the Development of Cytisine for Smoking Cessation

PR Newswire March 1, 2017

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Year End 2016

PR Newswire February 23, 2017

OncoGenex Pharmaceuticals, Inc. Announces Phase 2 Apatorsen Data for Two Clinical Trials Presented at the American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium

PR Newswire February 21, 2017

OncoGenex to Report Year End 2016 Financial Results on Feb. 23, 2017

PR Newswire February 16, 2017

Research Reports Coverage on Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold Pharma, and AmpliPhi Biosciences

PR Newswire January 26, 2017

OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement

PR Newswire January 5, 2017

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2016

PR Newswire November 10, 2016

OncoGenex to Report Third Quarter 2016 Financial Results on Nov. 10, 2016

Canada NewsWire November 3, 2016

Mid-Afternoon Market Update: Crude Oil Down Over 1.5%; NCR Shares Spike Higher

Benzinga.com  October 26, 2016

12 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  October 26, 2016

OncoGenex Announces Positive Survival Results from Apatorsen Phase 2 Borealis-2™ Trial in Metastatic Bladder Cancer

PR Newswire October 25, 2016

OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer

Canada NewsWire October 13, 2016